- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02334956
Linking fMRI to Mobile Technologies in Addiction Research: Pathophysiology of Executive Deficits, Craving and Substance Use (MobiCogIm)
Study Overview
Detailed Description
- Background : Despite the availability of both pharmacological and psychosocial treatments, most affected individuals will experience addiction as a chronic illness with severe consequences for health outcome. A fundamental challenge to researchers in this domain is therefore to understand the mechanisms leading to relapse. Among the key vulnerability factors associated with addiction chronicity, increasing attention has focused on deficits in executive functions and associated traits (impulsivity, risk taking) that are likely to explain why many individuals with addiction are unable to avoid high-risk contexts or to manage the experience of craving. Research concerning this vulnerability to relapse has been hindered by the manner in which cognitive deficits are traditionally assessed in clinical research. Most commonly, they are thought to represent stable risk factors that show little or no variation within a given individual. However, executive functioning may fluctuate rapidly over time (as does attention, memory, or other key cognitive functions), and therefore comparisons of overall or 'mean' cognitive deficits between healthy and substance-dependent individuals may show no significant differences despite powerful effects of this vulnerability. Therefore, the absence of measurement or characterization of this important relapse mechanism prevents any further research concerning its underlying pathophysiology.
- Purpose : Deficits in executive functioning may explain why many individuals with addiction are unable to avoid high-risk contexts or manage the experience of craving that lead to substance use. The principal objective of this project is to acquire resting state functional Magnetic Resonance Imaging (fMRI) and diffusion tensor imaging (DTI) data on patients with current addiction who will then complete (through a distinct protocol) mobile assessments of daily life executive fluctuations, craving, and substance use.
- Detailed description: 120 individuals with alcohol, cannabis or nicotine dependence as well as healthy controls will be administered a whole-brain imaging exam. The current research project constitutes a highly novel approach to understanding the pathophysiology of addiction through its combination of neuroimaging with state-of-the-art information collected through an independent investigation concerning the real-time expression of risk factors.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33000
- CHU de Bordeaux
-
Bordeaux, France, 33076
- Hôpital Charles Perrens
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria patient:
- Aged 18-64 years
- Being affiliated to health insurance
- Having signed an informed consent (later than the day of inclusion and before any examination required by research)
- Participation in the study MOBICOG for patients with addiction
- Fulfils diagnostic criteria for one of the following groups:
Group A: Patients with current (last 12 months) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) substance addiction (Alcohol / Cannabis / Nicotine); initiation of treatment for addiction within 30 days preceding enrollment in the study; absence of other axis 1 psychiatric disorder currently being treated (by psychotherapy or pharmacotherapy); absence of current or lifetime bipolar disorder or schizophrenia.
Group AM: Patients with current (last 12 months) DSM-IV substance addiction (Alcohol / Cannabis / Nicotine); initiation of treatment for addiction within 30 days preceding enrollment in the study; presence of currently treated unipolar mood disorder (by psychotherapy or pharmacotherapy); absence of current or lifetime bipolar disorder or schizophrenia.
Group AS: Patients currently treated for DSM-IV schizophrenia (last 12 months) with DSM-IV substance addiction (Alcohol / Cannabis / Nicotine); absence of other axis 1 psychiatric disorder currently being treated (by psychotherapy or pharmacotherapy); absence of current or lifetime bipolar disorder.
Inclusion criteria healthy volunteers:
- Aged 18-64 years
- Participation in the study MOBICOG
- Being affiliated to health insurance
- Having signed an informed consent (later than the day of inclusion and before any examination required by research)
- Healthy volunteers without current addiction and with no other currently-treated axis 1 DSM-IV disorder (by psychotherapy or pharmacotherapy); absence of current or lifetime bipolar disorder or schizophrenia
Exclusion Criteria:
- Presence of a counter-indication for MRI
- Presence of any health problem preventing travel to the imaging service of the University Hospital
- Being unable to provide consent to participate
- Pregnant or breastfeeding woman
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Patient
Patient with addiction
|
|
EXPERIMENTAL: Control
healthy subject
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Coefficient of correlation between inter-regional hemodynamic signals and clinical and neuropsychological data
Time Frame: After the MRI (D2 at 1 month after the inclusion)
|
After the MRI (D2 at 1 month after the inclusion)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Measurements of daily life functioning through recorded data about craving sensation and executive functioning
Time Frame: After the MRI (D2 at 1 month after the inclusion)
|
After the MRI (D2 at 1 month after the inclusion)
|
Measurements of brain structure, in relation to brain functioning
Time Frame: After the MRI (D2 at 1 month after the inclusion)
|
After the MRI (D2 at 1 month after the inclusion)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michèle ALLARD, Prof, CHU Bordeaux
- Study Director: Joel SWENDSEN, PhD, INCIA-UMR-CNRS 5287
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2014/19
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Addiction
-
The Hong Kong Polytechnic UniversityRecruiting
-
City University of Hong KongCompletedQuality of Life | Psychological Distress | Internet Gaming Disorder | Social Media Addiction | Smartphone AddictionChina
-
Gazi UniversityRecruitingAddiction | Physical Inactivity | Social Media AddictionTurkey
-
The Hong Kong Polytechnic UniversityRecruitingPrevalence of Internet Addiction and it's Effects on Psychological Well-being of Adults in Hong KongInternet AddictionHong Kong
-
Dr. Wang Man-PingActive, not recruiting
-
Mustafa YumusakCumhuriyet UniversityNot yet recruitingSmartphone Addiction | Students, NursingTurkey
-
Kutahya Health Sciences UniversityCompletedMental Fatigue | Smartphone AddictionTurkey
-
Bar-Ilan University, IsraelRecruitingInfant Behavior | Breastfeeding | Mother-Infant Interaction | Smartphone AddictionIsrael
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedSmartphone Users, Smartphone Addiction, Anxiety, and Skin ConductanceTaiwan
-
Suleyman Demirel UniversityCompleted
Clinical Trials on Brain MRI
-
University of NottinghamUnknownReversible Cerebral Vasoconstriction SyndromeUnited Kingdom
-
Sheba Medical CenterUnknown
-
Odense University HospitalRecruitingTelangiectasia, Hereditary Hemorrhagic | Intracranial Arteriovenous MalformationsDenmark
-
National Taiwan University HospitalRecruitingTourette Syndrome in ChildrenTaiwan
-
National Taiwan University HospitalUnknownEvaluation of Cerebral Small Vessel Disease in Patient With Primary AldosteronismTaiwan
-
National Taiwan University HospitalUnknownIntracerebral HemorrhageTaiwan
-
Yonsei UniversityRecruitingTriple Negative Breast Cancer | Metastatic Breast Cancer With HER2 PositiveKorea, Republic of
-
Centre Francois BaclesseCompleted
-
Assiut UniversityNot yet recruitingHypoxic Ischemic Encephalopathy